Pfizer/BioNTech: BNT162b2s01

Vaccine Type: RNA

This vaccine may also be referred to as BNT162b2SA

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 2 Trials

Phase 3: 1 Trial


This vaccine is not yet approved.

Registered Trials